Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
REGN

Regeneron

$438.17

6.79 (1.57%)

, AMGN

Amgen

$188.17

1.85 (0.99%)

07:44
09/21/17
09/21
07:44
09/21/17
07:44
Recommendations
Regeneron, Amgen, AstraZeneca, AbbVie analyst commentary at UBS »

Regeneron price target…

REGN

Regeneron

$438.17

6.79 (1.57%)

AMGN

Amgen

$188.17

1.85 (0.99%)

AZN

AstraZeneca

$32.93

0.26 (0.80%)

ABBV

AbbVie

$87.41

1.04 (1.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 25

    Sep

  • 27

    Sep

  • 02

    Dec

  • 03

    Feb

  • 30

    Apr

  • 17

    May

Tuesday
CYTK

Cytokinetics

$14.25

0.1 (0.71%)

, AMGN

Amgen

$186.47

-1 (-0.53%)

07:44
09/19/17
09/19
07:44
09/19/17
07:44
Hot Stocks
Cytokinetics doses first patient in Japan in GALACTIC-HF Phase 3 trial »

Cytokinetics announced…

CYTK

Cytokinetics

$14.25

0.1 (0.71%)

AMGN

Amgen

$186.47

-1 (-0.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 02

    Dec

  • 03

    Feb

  • 30

    Apr

  • 17

    May

Over a week ago
AMGN

Amgen

$189.44

-0.26 (-0.14%)

06:10
09/15/17
09/15
06:10
09/15/17
06:10
Hot Stocks
Amgen: FOURIER analysis shows Repatha reduces cardiovascular events »

Amgen announced that a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Dec

  • 03

    Feb

  • 30

    Apr

  • 17

    May

AMGN

Amgen

$189.44

-0.26 (-0.14%)

17:01
09/14/17
09/14
17:01
09/14/17
17:01
Initiation
Amgen initiated at RBC Capital »

Amgen initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Sep

  • 02

    Dec

  • 03

    Feb

  • 30

    Apr

  • 17

    May

AMGN

Amgen

$189.70

-1.3 (-0.68%)

, AGN

Allergan

$224.15

-2.325 (-1.03%)

14:58
09/14/17
09/14
14:58
09/14/17
14:58
Hot Stocks
FDA approves Amgen, Allergan's MVASI »

Amgen (AMGN) and Allergan…

AMGN

Amgen

$189.70

-1.3 (-0.68%)

AGN

Allergan

$224.15

-2.325 (-1.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Sep

  • 25

    Sep

  • 02

    Dec

  • 03

    Feb

  • 30

    Apr

  • 17

    May

AMGN

Amgen

$189.70

-1.3 (-0.68%)

12:18
09/14/17
09/14
12:18
09/14/17
12:18
Hot Stocks
FDA announces approval of Mvasi, first biosimilar approved in U.S. for cancer »

The U.S. Food and Drug…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Sep

  • 02

    Dec

  • 03

    Feb

  • 30

    Apr

  • 17

    May

AMGN

Amgen

$189.70

-1.3 (-0.68%)

, RHHBY

Roche

$31.49

-0.06 (-0.19%)

11:54
09/14/17
09/14
11:54
09/14/17
11:54
Hot Stocks
Amgen biosimilar of Roche's Avastin approved »

The FDA has granted Amgen…

AMGN

Amgen

$189.70

-1.3 (-0.68%)

RHHBY

Roche

$31.49

-0.06 (-0.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Sep

  • 30

    Nov

  • 02

    Dec

  • 03

    Feb

  • 30

    Apr

  • 17

    May

AMGN

Amgen

$189.70

-1.3 (-0.68%)

, RHHBY

Roche

$31.49

-0.06 (-0.19%)

11:49
09/14/17
09/14
11:49
09/14/17
11:49
Periodicals
Breaking Periodicals news story on Amgen, Roche »

Amgen biosimilar of…

AMGN

Amgen

$189.70

-1.3 (-0.68%)

RHHBY

Roche

$31.49

-0.06 (-0.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Sep

  • 30

    Nov

  • 02

    Dec

  • 03

    Feb

  • 30

    Apr

  • 17

    May

AGN

Allergan

$226.47

-4.74 (-2.05%)

, AMGN

Amgen

$189.70

-1.3 (-0.68%)

08:40
09/14/17
09/14
08:40
09/14/17
08:40
Conference/Events
Breaking Conference/Events news story on Allergan, Amgen »

FDA BsUFA Date for Amgen…

AGN

Allergan

$226.47

-4.74 (-2.05%)

AMGN

Amgen

$189.70

-1.3 (-0.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Sep

  • 25

    Sep

  • 02

    Dec

  • 03

    Feb

  • 30

    Apr

  • 17

    May

AMGN

Amgen

16:03
09/11/17
09/11
16:03
09/11/17
16:03
Hot Stocks
Amgen announces results from Phase 3 ARCH study »

Amgen and UCB announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Sep

  • 14

    Sep

  • 02

    Dec

  • 03

    Feb

  • 30

    Apr

  • 17

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.